Induction concurrent chemoradiotherapy using paclitaxel and carboplatin combination followed by surgery in locoregionally advanced non-small cell lung cancer - Asian experience

Annals of the Academy of Medicine Singapore

Volumn 37, Issue 5, 2008, Pages 377-382

  Yap, Swee Peng ^a   Lim, Wan Teck ^a   Foo, Kian Fong ^a   Hee, Siew Wan ^a   Leong, Swan Swan ^a   Fong, Kam Weng ^a   Eng, Philip ^b   Hsu, Anne A L ^b   Wee, Joseph T S ^a   Agasthian, Thirugnanam ^a   Koong, Heng Nung ^a   Tan, Eng Huat ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Chemoradiotherapy; Neoadjuvant treatment; Surgery

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ANEMIA; AREA UNDER THE CURVE; ARTICLE; ASIAN; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG FATALITY; EMPHYSEMA; ESOPHAGITIS; FEMALE; FOLLOW UP; HUMAN; INFECTION; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OVERALL SURVIVAL; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT FAILURE; WEIGHT REDUCTION;

EID: 45249122238     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Chia KS, Lee HP, Seow A, Shanmugaratnam K. Trends in cancer incidence in Singapore 1993-1997. Singapore: Singapore Cancer Registry Report No 5, 2000.
2. Dillman RO, Herndon J, Seagren SL, Eaton WL Jr, Green MR. Improved survival in Stage III non-small-cell lung cancer: seven-year follow-up of Cancer and Leukemic Group B (CALGB) 8433 trial. J Natl Cancer Inst 1996;88:1210-5.
3. Albain KS, Rusch VW, Crowly JJ, Rice TW, Turrisi AT 3rd, Weick JK, et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 1995;13:1880-92.
4. Choi NC, Carey RW, Daly W, Mathisen D, Wain J, Wright C, et al. Potential impact on survival of improved tumour downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer. J Clin Oncol 1997;15:712-22.
5. Eberhardt W, Wilke H, Stamatis G, Stuschke M, Harstrick A, Menker H, et al. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial. J Clin Oncol 1998;16:622-34.
6. Favaretto A, Paccagnella A, Tomio L, Sartori F, Cipriani A, Zuin R, et al. Preoperative chemoradiotherapy in non-small cell lung cancer stage III patients. Feasibility, toxicity and long term results of a phase II study. Eur J Cancer 1996;32A:2064-9.
7. Grunenwald D, LeChevalier T, Arriagada R, Le Pechoux C, Baldeyrou P, Bretel JJ, et al. Results of surgical resection in stage IIIB non small cell lung cancer after concomitant induction chemoradiatherapy. Lung Cancer l997;l8 Suppl 1:73.
8. Strauss GM, Herndon JE, Sherman DD, Mathisen DJ, Carey RW, Choi NC, et al. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung : report of a Cancer and Leukemic Group B phase II study. J Clin Oncol 1992;10: 1237-44.
9. Thomas M, Rube C, Semik M, Von Eiff M, Freitag L, Macha HN, et al. Impact of preoperative bimodality induction including twice-daily radiation on tumour regression and survival in stage III non-small-cell lung cancer. J Clin Oncol l999;l7:1185.
10. Albain KS, Swann RS, Rusch VS, Turrisi AT, Shepherd FA, Smith CJ, et al. Phase III study of concurrent chemotherapy and radiotherapy (CT/ RT) versus CT/RT followed by surgical resection for Stage IIIA (pN2) non-small cell lung cancer (NSCLC): Outcomes update of North America Intergroup 0139 ( RTOG 9309). J Clin Oncol 2005;23:7014.
11. Calvert AH, Newell DR, Gumbrell LA, O'Reilly S, Burnell M, Boxall FE, et al. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol l989;7:1748-56.
12. th ed. Philadelphia, PA: Lippincott, 1997: 858-911.
13. Mountain CF. Revisions in the International System for Staging Lung-Cancer. Chest l997;1 1:1710-7.
14. Le Chevalier T, Arriagada R, Quiox E, Ruffie P, Martin M, Douillard JY, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma. Lung Cancer 1994 March; 10 Suppl 1:S239-S244.
15. Pritchard RS, Anthony SP. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small cell lung cancer. A meta-analysis. Ann Intern Med 1996; 125:723-9. Erratum in Ann Intern Med l997;l26:670.
16. Mattson K, Holsti LR, Holsti P, Jakobsson M, Kajanti M, Lippo K, et al. Inoperable non-small cell lung cancer; radiation with or without chemotherapy. Eur J Cancer Clin Oncol 1988;24:477-82.
17. Sause W, Kolesar P, Taylor S IV, Johnson D, Livindston R, Komaki R, et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 2000;117:358-64.
18. Tan EH, Wee J, Ang PT, Fong KW, Leong SS, Khoo KS, et al. Induction chemotherapy followed by concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer. Acta Oncol 1999;38:1005-9.
19. Leong SS, Fong KW, Ong YK, Foo KF, Ang P, Wee J, et al. Chemoradiotherapy for stage III unresectable non-small cell lung cancer long-term results of a prospective study. Respir Med 2004;98:1080-6.
20. Byhardt RW, Scott C, Sause WT, Emami B, Komaki R, Fisher B, et al. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 1998;42:469-78.
21. Katakami N, Okazaki M, Nishiuchi S, Fukuda H, Horikawa T, Nishiyama H, et al. Induction chemoradiotherapy for advanced stage III non-small-cell lung cancer : long term follow-up in 42 patients. Lung Cancer 1998;22:127-37.
22. Takamari S, Rikiman T, Hayashi A, Tayama K, Mitsuoka M, Fujimoto K, et al. A preoperative alternating chemotherapy and radiotherapy program for patients with stage IIIA(N2) non-small-cell lung cancer. Lung Cancer 2000;29:49-56.
23. Ichinose Y, Fukuyama Y, Asoh H, Ushijima C, Okamoto T, Ikeda J, et al. Induction chemoradiotherapy and surgical resection for selected stage IIIB non-small-cell lung cancer. Ann Thorac Surg 2003;76:1810-5.